| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
bioMérieux S.A (PA: BIM)
BIM Technical Analysis
5
| As on 27th Feb 2026 BIM STOCK Price closed @ 100.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 115.07 & Strong Sell for SHORT-TERM with Stoploss of 107.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BIMSTOCK Price
| Open | 97.00 | Change | Price | % |
| High | 102.10 | 1 Day | 3.60 | 3.73 |
| Low | 96.60 | 1 Week | 5.80 | 6.16 |
| Close | 100.00 | 1 Month | -4.60 | -4.40 |
| Volume | 253909 | 1 Year | 0.95 | 0.96 |
| 52 Week High 128.30 | 52 Week Low 92.20 | ||||
PA France Most Active Stocks
| FTI | 5.91 | -1.66% |
| VIEDS | 0.72 | 4.35% |
| EDEN | 19.60 | 0.05% |
| ALNEV | 0.00 | % |
| BOL | 4.96 | -0.20% |
| DSY | 18.55 | 0.87% |
| CS | 41.46 | 1.47% |
| ALNRG | 0.01 | 0.00% |
| ORA | 18.19 | 1.96% |
| ALEUP | 0.04 | 33.33% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
| BIM Daily Charts |
BIM Intraday Charts |
Whats New @ Bazaartrend |
BIM Free Analysis |
|
|
BIM Important Levels Intraday
| RESISTANCE | 110.60 |
| RESISTANCE | 107.20 |
| RESISTANCE | 105.10 |
| RESISTANCE | 103.00 |
| SUPPORT | 97.00 |
| SUPPORT | 94.90 |
| SUPPORT | 92.80 |
| SUPPORT | 89.40 |
BIM Forecast March 2026
| 4th UP Forecast | 124.09 |
| 3rd UP Forecast | 116.36 |
| 2nd UP Forecast | 111.59 |
| 1st UP Forecast | 106.81 |
| 1st DOWN Forecast | 93.19 |
| 2nd DOWN Forecast | 88.41 |
| 3rd DOWN Forecast | 83.64 |
| 4th DOWN Forecast | 75.91 |
BIM Weekly Forecast
| 4th UP Forecast | 111.95 |
| 3rd UP Forecast | 108.12 |
| 2nd UP Forecast | 105.75 |
| 1st UP Forecast | 103.38 |
| 1st DOWN Forecast | 96.62 |
| 2nd DOWN Forecast | 94.25 |
| 3rd DOWN Forecast | 91.88 |
| 4th DOWN Forecast | 88.05 |
BIM Forecast2026
| 4th UP Forecast | 170.24 |
| 3rd UP Forecast | 147.71 |
| 2nd UP Forecast | 133.79 |
| 1st UP Forecast | 119.87 |
| 1st DOWN Forecast | 80.13 |
| 2nd DOWN Forecast | 66.21 |
| 3rd DOWN Forecast | 52.29 |
| 4th DOWN Forecast | 29.76 |
bioMérieux S.A ( PA France Symbol : BIM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BIM Other Details
| Segment | EQ | |
| Market Capital | 12825134080.00 | |
| Sector | Healthcare | |
| Industry | Diagnostics & Research | |
| Offical website | > echo $website ; ?> | |
BIM Address
![]() |
||
BIM Latest News
BIM Business Profile
bioMérieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA. Address: 376 Chemin De l?Orme, Marcy l'Étoile, France, 69280
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

